EU has Amended the Annex XIV Entries to REACH of DEHP, BBP, DBP and DIBP
Published: Author: Visits: 1414

On 23 December 2021, the European Union has released the COMMISSION REGULATION (EU) 2021/2045 to amend the Entry 4-7 (DEHP, BBP, DBP and DIBP) to REACH Annex XIV.

The amendments are as follows:

Entry Nr

Substance

Intrinsic property(ies) referred to in Article 57

Transitional arrangements

Exempted (categories of) uses

Review periods

Latest application date

Sunset date

4

Bis(2-ethylhexyl) phthalate (DEHP)

EC No: 204-211-0

CAS No: 117-81-7

Toxic for reproduction

(category 1B)

Endocrine disrupting

properties (Article 57(f) – human health)

Endocrine disrupting properties (Article 57(f) –

environment)

a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in:

— food contact materials within the scope of Regulation (EC) No 1935/2004;

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DEHP at or above 0,1 % and below 0,3 % weight by weight;

(c) By derogation of point (a):

27 November 2023 for uses in medical devices within the scope of Directives 90/385/EEC, 93/42/EEC and 98/79/EC.

(a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in:

— food contact materials within the scope of Regulation (EC) No 1935/2004;

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DEHP at or above 0,1 % and below 0,3 % weight by weight;

(c) By derogation of point (a):

27 May 2025 for uses in medical devices within the scope of Directives 90/385/EEC, 93/42/EEC and 98/79/EC.

-

-

5

Benzyl butyl phthalate (BBP)

EC No: 201-622-7

CAS No: 85-68-7

Toxic for reproduction

(category 1B)

Endocrine disrupting properties (Article 57(f) – human health)

a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in:

— immediate packaging of medicinal products covered under Regulation

(EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing BBP at or above 0,1 % and below 0,3 % weight by weight.

a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing BBP at or above 0,1 % and below 0,3 % weight by weight.

-

-

6

Dibutyl phthalate (DBP)

EC No: 201-557-4

CAS No: 84-74-2

Toxic for reproduction (category 1B)

Endocrine disrupting properties (Article 57(f) –

human health)

a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DBP at or above 0,1 % and below 0,3 % weight by weight.

a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in:

— immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC;

— mixtures containing DBP at or above 0,1 % and below 0,3 % weight by weight.

-

-

7

Diisobutyl phthalate (DIBP)

EC No: 201-553-2

CAS No: 84-69-5

Toxic for reproduction (category 1B)

Endocrine disrupting properties (Article 57(f) – human health)

a) 21 August 2013 (*)

(b) By way of derogation from point (a):

14 June 2023 for uses in mixtures containing DIBP at or above 0,1 % and below 0,3 % weight by weight.

(a) 21 February 2015 (**)

(b) By way of derogation from point (a):

14 December 2024 for uses in mixtures containing DIBP at or above 0,1 % and below 0,3 % weight by weight.

-

-

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

If you have any needs or questions, please contact us at test@cirs-group.com.

Further Information

Official Journal of the European Union